Wisconsin effort launches to move precision medicine forward

Precision Medicine Molecular Tumor Board
Dr. Marc Drezner

A $5.3M grant from the National Institutes of Health for precision medicine research is being shared by three institutions in Wisconsin: University of Wisconsin School of Medicine and Public Health (UW SMPH), Medical College of Wisconsin, and Marshfield Clinic.

Marc Drezner, MD, professor, Endocrinology, Diabetes, and Metabolism and senior associate dean for translational research, UW SMPH, was quoted in a story about Wisconsin's involvement in the nationwide All of Us Research Program, which seeks to enroll more than 1M people across the United states, 8,000 of whom will be recruited from Wisconsin.

All of Us aims to enable individualized prevention, treatment, and medical care based on one's genetics, environment, and lifestyle.

"Genetic abnormalities often are brought forward by the environment in which individuals exist, the behaviors that they practice," said Dr. Drezner. "The opportunity we have now is to try and combine all of (lifestyle, genetics and environment)."

Resources:

photo: Members of the UW Carbone Cancer Center Precision Medicine Molecular Tumor Board (PMMTB) perform case reviews to make personalized medicine recommendations based on DNA mutations found in a patient's tumor. Credit: Clint Thayer/Department of Medicine